Abstract

SummaryThe regression discontinuity (RD) design is a quasi-experimental design which emulates a randomized study by exploiting situations where treatment is assigned according to a continuous variable as is common in many drug treatment guidelines. The RD design literature focuses principally on continuous outcomes. We exploit the link between the RD design and instrumental variables to obtain an estimate for the causal risk ratio for the treated when the outcome is binary. Occasionally this risk ratio for the treated estimator can give negative lower confidence bounds. In the Bayesian framework we impose prior constraints that prevent this from happening. This is novel and cannot be easily reproduced in a frequentist framework. We compare our estimators with those based on estimating equation and generalized methods-of-moments methods. On the basis of extensive simulations our methods compare favourably with both methods and we apply our method to a real example to estimate the effect of statins on the probability of low density lipoprotein cholesterol levels reaching recommended levels.

Highlights

  • The Regression Discontinuity (RD) design is a quasi-experimental design introduced in the 1960’s in Thistlethwaite and Campbell [1960] and widely used in economics and related social sciences (Imbens and Lemieux [2008]) and more recently in the medical sciences (Geneletti et al [2015], Bor et al [2014])

  • The RD design naturally leads to an Instrumental Variable (IV) analysis and so we adapt the IV based Multiplicative Structural Mean Model (MSMM) Risk Ratio for the Treated (RTT) estimator (Clarke and Windmeijer [2012, 2010], Hernan and Robins [2006]) to this context

  • Naive Bayesian estimators of the MSMM ratio for the treated (RRT) suffer from this problem; we circumvent this issue by imposing prior constraints that prevent the posterior MCMC sample from dropping below zero

Read more

Summary

Introduction

The Regression Discontinuity (RD) design is a quasi-experimental design introduced in the 1960’s in Thistlethwaite and Campbell [1960] and widely used in economics and related social sciences (Imbens and Lemieux [2008]) and more recently in the medical sciences (Geneletti et al [2015], Bor et al [2014]). The RD design naturally leads to an Instrumental Variable (IV) analysis and so we adapt the IV based Multiplicative Structural Mean Model (MSMM) Risk Ratio for the Treated (RTT) estimator (Clarke and Windmeijer [2012, 2010], Hernan and Robins [2006]) to this context. Naive Bayesian estimators of the MSMM RRT suffer from this problem; we circumvent this issue by imposing prior constraints that prevent the posterior MCMC sample from dropping below zero. This is a novel implementation of prior constraints and cannot be reproduced in a frequentist framework.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call